US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

登録

ホーム
投資
株式
アメリカ
NYSE
Johnson and Johnson (JNJ)
Johnson and Johnson (JNJ) ニュース

JNJ

Johnson and Johnson (JNJ)

Johnson and Johnson

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NYSE:JNJ

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/01	19 : 30	Business Wire	Johnson & Johnson Announces Plan by its Subsidiary, LLT Management LLC, to Resolve All Current and Future Ovarian Cancer Talc Claims Through a Consensual “Prepackaged” Reorganization	NYSE:JNJ	Johnson and Johnson
2024/04/23	05 : 30	Business Wire	Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)	NYSE:JNJ	Johnson and Johnson
2024/04/19	20 : 31	IH Market News	Paramount’s Shares Surge Following Sony and Apollo’s Joint Bid; ISS Backs Berkshire Hathaway Director Re-election, and More	NYSE:JNJ	Johnson and Johnson
2024/04/17	19 : 59	IH Market News	US Index Futures See Gains, Oil Prices Dip	NYSE:JNJ	Johnson and Johnson
2024/04/17	05 : 33	IH Market News	U.S. Stocks Finish Lackluster Session Narrowly Mixed	NYSE:JNJ	Johnson and Johnson
2024/04/16	23 : 46	Business Wire	CORRECTING and REPLACING Johnson & Johnson Reports Q1 2024 Results	NYSE:JNJ	Johnson and Johnson
2024/04/16	22 : 52	IH Market News	J&J’s Q1 2024 sales rise 2.3% to $21.4 billion	NYSE:JNJ	Johnson and Johnson
2024/04/16	22 : 09	IH Market News	Dow Looks To Snap Six-Day Losing Streak As UnitedHealth Surges	NYSE:JNJ	Johnson and Johnson
2024/04/16	20 : 19	IH Market News	U.S. Index Futures Signal Mixed Trading, Oil Prices Dip	NYSE:JNJ	Johnson and Johnson
2024/04/16	20 : 18	IH Market News	Ericsson Soars with 66% Net Profit Growth; Live Nation Under Antitrust Scrutiny in US, and More News	NYSE:JNJ	Johnson and Johnson
2024/04/16	19 : 25	Business Wire	Johnson & Johnson Announces 62nd Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 4.2%	NYSE:JNJ	Johnson and Johnson
2024/04/16	19 : 20	Business Wire	Johnson & Johnson Reports Q1 2024 Results	NYSE:JNJ	Johnson and Johnson
2024/04/16	05 : 38	IH Market News	U.S. Stocks Extend Sell-Off As Treasury Yields Surge After Retail Sales Data	NYSE:JNJ	Johnson and Johnson
2024/04/09	07 : 06	Business Wire	Johnson & Johnson to Participate in the 2024 RBC Capital Markets Global Healthcare Conference	NYSE:JNJ	Johnson and Johnson
2024/04/06	12 : 21	PR Newswire (US)	CARVYKTI® is the First and Only BCMA-Targeted Treatment Approved by the U.S. FDA for Patients with Relapsed or Refractory Multiple Myeloma Who Have Received at Least One Prior Line of Therapy	NYSE:JNJ	Johnson and Johnson
2024/04/06	03 : 55	PR Newswire (US)	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc.	NYSE:JNJ	Johnson and Johnson
2024/04/05	20 : 38	IH Market News	Apple Terminates 614 Employees, Disney Unveils June Crackdown on Password Sharing, and More Updates	NYSE:JNJ	Johnson and Johnson
2024/04/05	19 : 31	Business Wire	Johnson & Johnson to Acquire Shockwave Medical	NYSE:JNJ	Johnson and Johnson
2024/04/05	07 : 01	Business Wire	Johnson & Johnson Recommends Shareholders Reject “Mini-Tender” Offer by TRC Capital Investment Corporation	NYSE:JNJ	Johnson and Johnson
2024/04/03	05 : 30	Business Wire	Johnson & Johnson to Participate in the BofA Securities Health Care Conference	NYSE:JNJ	Johnson and Johnson
2024/03/28	22 : 48	IH Market News	Walgreens Slashes Annual Profit Forecast; MillerKnoll Nosedives 17% on Bleak 4Q Outlook, and Latest News	NYSE:JNJ	Johnson and Johnson
2024/03/27	19 : 54	IH Market News	GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News	NYSE:JNJ	Johnson and Johnson
2024/03/12	22 : 15	GlobeNewswire Inc.	Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge	NYSE:JNJ	Johnson and Johnson
2024/03/12	05 : 30	Business Wire	Johnson & Johnson to Host Investor Conference Call on First-Quarter Results	NYSE:JNJ	Johnson and Johnson
2024/03/08	06 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson
2024/03/08	06 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson
2024/03/07	22 : 33	Business Wire	Johnson & Johnson Completes Acquisition of Ambrx	NYSE:JNJ	Johnson and Johnson
2024/03/07	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson
2024/03/02	05 : 59	PR Newswire (US)	RYBREVANT® (amivantamab-vmjw) in Combination With Chemotherapy Is the First FDA Approved Therapy for First-line Treatment of Patients With Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations	NYSE:JNJ	Johnson and Johnson
2024/02/21	07 : 58	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:JNJ	Johnson and Johnson

Showing the most relevant articles for your search:NYSE:JNJ

1 2 3 4 5 6 7 8 9 10 次へ >>

Gold vs US Dollar

Deutsche Telekom (QX)

US Dollar vs Yen

JP Morgan Chase

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約